Search
Edgewise Therapeutics Inc
EWTXAdd to Watchlist
45.320USD
-1.620-3.45%
Close 09-18 16:00（ET）
4.89BMarket Cap
LossP/E TTM
After-hours 16:13 (ET)45.220USD-0.150-0.33%
After-hours 16:13 (ET)Edgewise Therapeutics Inc (EWTX) Stock Price Target & Forecast
Analyst Rating
Based on 13 analysts giving stock ratings to Edgewise Therapeutics Inc in the past month.
Buy
5 Strong Buy
6 Buy
2 Hold
0 Sell
0 Strong Sell
Target Price
51.000USD+16.89%
EWTX Analyst Recommendation Trends
In the current month, EWTX has received 6 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. EWTX average Analyst price target in the last month is 51.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
5
5
4
4
4
4
4
4
6
6
6
6
6
6
6
6
2
2
2
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13
13
12
12
12
12
12
12
Financial Forecasting
Based on analysts' estimates, EWTX EPS is projected to reach 3.403 in FY2026Q3, following reported EPS of -0.532 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.44
-0.49
-0.47
3.40
-0.48
Actual
-0.47
-0.46
-0.53
--
--
Surprise
-8.65%
+5.98%
-13.28%
--
--
FAQs
What is Edgewise Therapeutics Inc's price target?
Analysts forecast that Edgewise Therapeutics Inc's price target is USD 41.00, with the highest forecast at USD 50.00 and the lowest forecast at USD 14.00.
How have Edgewise Therapeutics IncEWTX's recent earnings per share performed?
The market expectation was USD -0.53, while Edgewise Therapeutics IncEWTX's earnings per share (EPS) for the previous quarter was USD -0.46. EPS for the next quarter is expected at USD 3.40.
What is the analyst rating for Edgewise Therapeutics Inc?
Based on the ratings of Edgewise Therapeutics Inc's stock from 13 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.